Calamos Advisors LLC Astrazeneca PLC Transaction History
Calamos Advisors LLC
- $16.8 Billion
- Q4 2024
A detailed history of Calamos Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Calamos Advisors LLC holds 12,139 shares of AZN stock, worth $878,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,139
Previous 12,069
0.58%
Holding current value
$878,378
Previous $940,000
15.43%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,339Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.55 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.04 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.7 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.66 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...